Morning Hubs! Hope all is well with you and yours. We’re still trying to pull out of stubborn winter here in the northeast. I’m just starting to gear up to work on our upcoming emerging manager project that runs in June – if you have thoughts on great new PE shops or have thoughts on the landscape for emerging firms, hit me up at christopher.w@ pei.group. • SKKY Partners' David Brisske talks about joining the firm, its first deal • Blackstone Life Sciences agrees to fund up to $750m in Moderna's flu program • Wellspring to close nearly $1bn multi-asset continuation fund Flu Blackstone agreed to provide up to $750 million to finance Moderna’s influenza program. Blackstone is funding the deal through its life sciences program. Upgrade to the full version of the Wire to read more. Consumer PE Hub sat down with David Brisske, a managing director with new shop SKKY Partners formed by Kim Kardashian and ex-Carlyle Group consumer chief Jay Sammons. Brisske talked about his backstory and how he came to find himself working for a firm led by a guy he once competed with. Read a snippet from the interview at the premium version of the Wire. Big one Wellspring Capital is closing a nearly $1 billion multi-asset continuation fund deal that will extend its hold over three companies from the firm’s sixth fund, Buyouts reported. The deal, expected to close today, is being co-led by Neuberger Berman and Lexington Partners, with a syndicate of smaller investors including Hamilton Lane, AltamarCAM Partners, some Fund VI LPs and a commitment from the GP. Campbell Lutyens worked as secondaries adviser on the deal. Read the full story here on Buyouts. That’s it for me! Have a great rest of your Wednesday. Hit me up with your juicy tips n’ gossip at [email protected] or find me on LinkedIn. Read the full wire commentary on PE Hub ... |